-
10 possible signs of Alzheimer's — and how the disease affects Hispanic people
The Alzheimer’s Association created a list of early signs of the disease or other types of dementia. In the United States, the disease disproportionately affects Hispanic patients.
-
Bob Barker died from Alzheimer's disease, death certificate states
Barker died at age 99 from Alzheimer’s disease and other contributing factors, as outlined in his death certificate.
-
Some insurers won't cover new Alzheimer's treatment shown to slow decline
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.
-
Finger prick blood test could revolutionize Alzheimer's disease diagnosis, research shows
Researchers say the finger prick would be quick and non-invasive, and samples could be taken at home, then easily transported for testing.
-
Alzheimer's disease most prevalent in Miami-Dade
A new study reveals Miami-Dade County has the highest prevalence of people with Alzheimer’s and dementia in the U.S. NBC6’s Kim Wynne reports
-
Study shows Eli Lilly's Alzheimer's drug slows memory decline but with safety risks
If U.S. regulators approve, the drug would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after rival Leqembi. Both drugs pose a serious safety concern — brain swelling and bleeding.
-
Miami-Dade has highest prevalence of people with Alzheimer's, dementia in the US, new research finds
New research released Monday at the Alzheimer’s Association International Conference in Amsterdam revealed that Miami-Dade County has the highest prevalence of people with Alzheimer’s and dementia in the U.S.
-
FDA grants full approval to new Alzheimer's drug
A new study has led the Food and Drug Administration to grant full approval to a new Alzheimer’s treatment.
-
FDA approves Alzheimer's drug Leqembi, paving way for broader Medicare coverage
Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.
-
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
U.S. health advisers are backing the full approval of an Alzheimer’s drug that received preliminary approval last year. A panel of advisers to the Food and Drug Administration on Friday voted in favor of the infused medication from drugmakers Eisai and Biogen. The FDA granted accelerated approval in January based on early results suggesting the drug could modestly slow Alzheimer’s....
-
Experimental Drug Slows Worsening Effects of Alzheimer's
Eli Lilly and Co. said Wednesday its experimental Alzheimer’s drug appeared to slow worsening of the mind-robbing disease in a large study. NBC 5’s Bianca Castro talked with Frisco neurologist Dr. Aimee Garza about how it works.
-
Woman With Alzheimer's Disappears After Flight to Miami
Authorities are investigating an early morning police-involved shooting in Wynwood Sunday that left one man injured, police said. NBC 6’s Kim Wynne reports.
-
Experimental Drug Shows Signs of Slowing Cognitive Decline in Alzheimer's Patients, Study Finds
New data shows an experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening. The next question is how much difference that might make in people’s lives.